A rapid method was developed and validated to determine VPA in blood by ultra-performance liquid chromatography (UPLC) coupled with tandem mass spectrometry (MS/MS) with electrospray ionization source in negative ion mode.
The method involved sample treatment with phosphoric acid followed by solid-phase extraction. Chromatographic separation was achieved using an Acquity UPLC? BEH (2.1?¡Á?50?mm id, 1.7?¦Ìm) column and a mobile phase containing ammonium acetate and acetonitrile, at a 0.5?mL/min flow rate. Detection and quantification of VPA was achieved using multiple reaction monitoring (MRM). The MS/MS transitions used for monitoring were m/z 143.1?43.1 for valproic acid and m/z 296.1?05.0 for hydrochlorothiazide used as an internal standard (IS).
The limit of quantification (LOQ) was 0.5?¦Ìg/mL and the method was linear in the concentration range of 0.5?00?¦Ìg/mL. The coefficients of variation obtained for accuracy and precision were less than 10 % and the mean recovery was 95 % for the three concentrations levels studied (5?¦Ìg/mL, 10?¦Ìg/mL and 50?¦Ìg/mL). Toxicological results showed high concentration of VPA (556?¦Ìg/mL) and therapeutic concentrations of tiapride, mirtazapine, oxazepam and nordiazepam. Blood sample analysis also revealed the presence of ethanol at a concentration of 1.34?g/L.
A specific, selective and sensitive method for the determination of VPA in blood was developed and can be used in routine forensic investigation. Toxicological results led the pathologist to rule that death was due to an intoxication caused by the simultaneous ingestion of high VPA concentrations and alcohol, with a suicidal legal-medical etiology.